Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 319

1.

The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes.

Hur J, Dauch JR, Hinder LM, Hayes JM, Backus C, Pennathur S, Kretzler M, Brosius FC 3rd, Feldman EL.

Diabetes. 2015 May 15. pii: db150133. [Epub ahead of print]

PMID:
25979075
2.

The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain.

Sims-Robinson C, Bakeman A, Rosko A, Glasser R, Feldman EL.

Mol Neurobiol. 2015 May 15. [Epub ahead of print]

PMID:
25976368
3.

Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.

Goutman SA, Feldman EL.

JAMA Neurol. 2015 May 11. doi: 10.1001/jamaneurol.2014.4275. [Epub ahead of print] No abstract available.

PMID:
25961436
4.

Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL.

Nat Rev Neurol. 2015 May;11(5):266-279. doi: 10.1038/nrneurol.2015.57. Epub 2015 Apr 21. Review.

PMID:
25896087
5.

Histological Bulbar Manifestations in the ALS Rat.

Kashlan ON, Kashlan BN, Oh SS, McGinley LM, Chen KS, Kupfer R, Erman A, Sakowski SA, Feldman EL.

Neurodegener Dis. 2015;15(2):121-6. doi: 10.1159/000377725. Epub 2015 Mar 24.

PMID:
25825172
6.

The spectrum of motor neuron diseases: from childhood spinal muscular atrophy to adult amyotrophic lateral sclerosis.

Sakowski SA, Feldman EL.

Neurotherapeutics. 2015 Apr;12(2):287-9. doi: 10.1007/s13311-015-0349-7. No abstract available.

PMID:
25794940
7.

Recent advances and the future of stem cell therapies in amyotrophic lateral sclerosis.

Goutman SA, Chen KS, Feldman EL.

Neurotherapeutics. 2015 Apr;12(2):428-48. doi: 10.1007/s13311-015-0339-9.

PMID:
25776222
8.

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.

Kim B, Feldman EL.

Exp Mol Med. 2015 Mar 13;47:e149. doi: 10.1038/emm.2015.3. Review.

9.

Circuits and circuit disorders: approaches to neuromodulation: call for papers and new initiative with the american neurological association and the annals of neurology.

Rosenberg RN, Feldman EL.

JAMA Neurol. 2015 Apr 1;72(4):385. doi: 10.1001/jamaneurol.2015.0117. No abstract available.

PMID:
25730466
10.

The dual roles of immunity in ALS: Injury overrides protection.

Murdock BJ, Bender DE, Segal BM, Feldman EL.

Neurobiol Dis. 2015 May;77:1-12. doi: 10.1016/j.nbd.2015.02.017. Epub 2015 Feb 26. Review.

PMID:
25726748
11.

The evaluation of distal symmetric polyneuropathy: utilisation and expenditures by community neurologists.

Callaghan BC, Kerber KA, Banerjee M, Feldman EL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Lisabeth LD.

J Neurol Neurosurg Psychiatry. 2015 Jan 20. pii: jnnp-2014-307575. doi: 10.1136/jnnp-2014-307575. [Epub ahead of print] No abstract available.

PMID:
25604430
12.

Autocrine production of igf-I increases stem cell-mediated neuroprotection.

Lunn JS, Sakowski SA, McGinley LM, Pacut C, Hazel TG, Johe K, Feldman EL.

Stem Cells. 2015 May;33(5):1480-9. doi: 10.1002/stem.1933.

PMID:
25532472
13.

Hyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves.

Hamid HS, Mervak CM, M√ľnch AE, Robell NJ, Hayes JM, Porzio MT, Singleton JR, Smith AG, Feldman EL, Lentz SI.

Ann Clin Transl Neurol. 2014 Oct;1(10):799-812. doi: 10.1002/acn3.119. Epub 2014 Oct 1.

14.

Therapeutic hypothermia and targeted temperature management after cardiac arrest-reply.

Little NE, Feldman EL.

JAMA Neurol. 2014 Dec;71(12):1578. doi: 10.1001/jamaneurol.2014.3128. No abstract available.

PMID:
25486211
15.

BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses.

O'Brien PD, Hur J, Hayes JM, Backus C, Sakowski SA, Feldman EL.

Neurobiol Dis. 2014 Oct 30;73C:348-355. doi: 10.1016/j.nbd.2014.10.015. [Epub ahead of print]

PMID:
25447227
16.

Therapy for diabetic neuropathy: an overview.

Calabek B, Callaghan B, Feldman EL.

Handb Clin Neurol. 2014;126:317-33. doi: 10.1016/B978-0-444-53480-4.00022-9.

PMID:
25410231
17.

Global metabolomic and isobaric tagging capillary liquid chromatography-tandem mass spectrometry approaches for uncovering pathway dysfunction in diabetic mouse aorta.

Filla LA, Yuan W, Feldman EL, Li S, Edwards JL.

J Proteome Res. 2014 Dec 5;13(12):6121-34. doi: 10.1021/pr501030e. Epub 2014 Nov 13.

PMID:
25368974
18.

Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes.

Gallagher KA, Joshi A, Carson WF, Schaller M, Allen R, Mukerjee S, Kittan N, Feldman EL, Henke PK, Hogaboam C, Burant CF, Kunkel SL.

Diabetes. 2015 Apr;64(4):1420-30. doi: 10.2337/db14-0872. Epub 2014 Nov 3.

PMID:
25368099
19.

Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs.

Callaghan BC, Feldman EL.

Ann Intern Med. 2014 Nov 4;161(9):674-5. doi: 10.7326/M14-2157. No abstract available.

PMID:
25364890
20.

Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis.

Foerster BR, Carlos RC, Dwamena BA, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Barker PB, Feldman EL, Pomper MG.

Ann Clin Transl Neurol. 2014 Feb;1(2):107-14. doi: 10.1002/acn3.30. Epub 2014 Jan 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk